Home » Topics » BioWorld Science

BioWorld Science
RSS

SHISA4 expression proven useful to monitor nintedanib therapy in patients with IPF

May 14, 2020

Immunic receives approval to begin phase II study of IMU-838 for COVID-19

May 14, 2020

Blueprint Medicines' BLU-847 shows activity against wild-type and mutant tyrosine kinase receptors

May 14, 2020

Improved therapeutic index could reduce opioid toxicity

May 14, 2020

miRNA-126-5p circulating levels are decreased in severe sepsis

May 14, 2020

New adenosine A2A and A2B receptors disclosed by Merck KGaA

May 14, 2020

ViiV Healthcare discovers new HIV-1 Capsid protein p24 assembly inhibitors

May 14, 2020

Nurix Therapeutics patents Bruton tyrosine kinase-degrading compounds

May 14, 2020

Ascletis receives IND approval in China for clinical development of ASC-41 in NASH

May 14, 2020

Insilico Medicine Hong Kong discovers DDR1 inhibitors

May 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...